Scilex Holding Company announced the publication of a study in Pain Medicine News revealing that patients treated with ZTlido® (lidocaine topical system 1.8%) showed a greater reduction in opioid use ...
Scilex (SCLX) announced that Pain Medicine News published retrospective claims data on ZTlido vs. lidocaine 5% patch. Pain Medicine News, the premier trade publication in the pain management space, ...
Scilex Holding Company, an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, ...
Under Section 561A (f) (2) of the United States Federal Food, Drug, and Cosmetic Act, Scilex is required to make our expanded access policy for SP-103 (lidocaine topical system) 5.4% publicly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback